Johnson & Johnson vs Solventum Corporation
JNJ vs SOLV — side-by-side comparison from reported financials. JNJ leads 6, SOLV leads 4 of 10 comparable metrics.
Johnson & Johnson
JNJ · Healthcare
$261.79+2.07%Mixed
Solventum Corporation
SOLV · Healthcare
$87.88+1.70%Strained
| Metric | JNJ | SOLV |
|---|---|---|
| Price | $261.79 | $87.88 |
| Market cap | $631B | $15.0B |
| Revenue (TTM) | $97.9B | $8.31B |
| Revenue growth | +5.6% | +0.8% |
| Net margin | 21.5% | 17.3% |
| Free cash flow | $22.2B | -$118M |
| Net cash (debt) | ($27.8B) | ($4.16B) |
| 1-year price return | +37.0% | +22.4% |
| P/E | 29.9 | 10.4 |
| P/E vs own history (cheap-side %) | 16% | 66% |
| Dividend yield | 2.00% | — |
| Return on equity | 26% | 29% |
| CV checks passed | 10 of 11 | 6 of 11 |
| Employees | 140,800 | 20,000 |
Full résumé-style profiles: JNJ CV · SOLV CV
Green marks the stronger side on comparable metrics. Figures are derived from company filings and may be delayed, restated or incomplete — information, not investment advice.